But its new cost-cutting drive threatens to hit the creative ecosystem that sustains thousands of jobs and has become central to the continent’s cultural exportsBut its new cost-cutting drive threatens to hit the creative ecosystem that sustains thousands of jobs and has become central to the continent’s cultural exports

Africa’s creatives face pressure as Canal+ plans content and operations cuts

4 min read

Africa’s independent producers, suppliers, and creative workers are set to feel the strain as the French media giant Canal+, which recently acquired Multichoice, Africa’s biggest pay-TV company,  rolls out cost-cutting measures to stabilise its balance sheet.

In the past two financial years, MultiChoice lost 2.8 million linear subscribers as rising household costs and global streaming competition weighed heavily on its pay-TV business. 

On Thursday, 29 January, its new owner, Canal+, announced a plan to save more than €400 million ($478 million) annually by 2030, to stabilise the business by cutting content, technology and operations costs. 

Now under Canal+, MultiChoice has been Africa’s largest buyer of local TV and film. But its new cost-cutting drive threatens to hit the creative ecosystem that sustains thousands of jobs and has become central to the continent’s cultural exports. 

For a sector already struggling with rising costs and changing viewer habits, these cuts could undo years of growth and creativity. And threaten to transform an era of peak TV into a survival-of-the-fittest landscape where only the most commercial, low-risk productions survive.

“MultiChoice’s cost-cutting is increasingly unavoidable rather than optional,” said Thabo Mosala, the director of Wrenjos Consulting, a strategy and leadership consulting firm. 

He notes that maintaining a legacy cost base in a shrinking market is no longer viable, and Canal+ has prioritised restoring financial health through strict cost discipline rather than open-ended investment.

In October 2025, barely weeks after finalising its takeover, Canal+ reportedly asked MultiChoice suppliers for a blanket 20% cut on all invoices, from office vendors to production houses and new contractors. 

Because merger rules prevent immediate job cuts, Canal+ insists it will not raise subscription fees for DStv packages that could affect its customers. Instead, most of the cost-cutting is being pushed onto MultiChoice’s wider network of suppliers, including those providing content.

Read: Canal+ risks probe after demanding 20% discount from MultiChoice suppliers

According to Adrian Galley, vice-chair of the South African Guild of Actors (SAGA), “many producers were already accepting ‘minimal budgets’ and throttling the entire production value chain to survive, so a further 20% cut on invoices, sometimes after delivery, risks’ catastrophic harm’ to livelihoods and long-term sector sustainability.”

Mosala points out that now cost reductions are flowing through procurement cuts, reduced commissioning budgets, and tighter contract terms, shifting employment pressure into the broader ecosystem of independent production houses, technical suppliers, and freelancers. 

These players now face fewer projects, thinner margins, and greater uncertainty, which translates into fewer gig opportunities and slower skills development, even if MultiChoice’s internal headcount remains largely stable for now.

Galley says that such cost-cutting measures erode trust, undermine years-long relationships, and contradict assurances given to regulators that local content and diverse procurement would be protected under the merger. 

Local content, long a strategic differentiator for MultiChoice, is emerging as a major fault line. As subscriber revenue declines, there is less room to fund a high volume of originals, which leads to fewer commissions, more conservative commissioning decisions, and less tolerance for creative risk. 

Mosala warns that, over time, this dynamic could weaken the local content pipeline, hollow out production capacity, and erode employment in the creative economy, unless cost-cutting is carefully managed to avoid permanent damage to the very ecosystem that underpins MultiChoice’s relevance.

Showmax’s struggles and the hit-driven future of African originals

On an investor call on Thursday, 29 January, Canal+ CEO Maxime Saada described Showmax as “not a commercial success” and a significant drag on MultiChoice’s financial performance. 

He noted that past investments in marketing, content, and technology for the platform were too high relative to returns, and signalled plans to reduce them as part of the synergy programme.

This stance unsettles African producers who have seen Showmax and DStv more broadly as crucial outlets for local storytelling and as cultural infrastructure for the continent’s film and TV industries. 

If Showmax is repositioned primarily through a profitability lens, budgets are likely to tilt even more strongly towards titles with clear commercial upside. 

In practice, that favours breakout, high-impact series like Shaka iLembe, the 12-part historical drama that ranked among Showmax’s most-watched dramas on DStv, attracted over 7.5 million viewers on its return, and set a new first-day viewing record on Showmax.

Canal+ continues to frame the MultiChoice deal as a long-term bet on Africa’s demographic and economic fundamentals: fast population growth, rising incomes, greater electrification, and deeper pay-TV and streaming penetration. 

The group points to MultiChoice’s expansion to over 40 million subscribers in the past decade as evidence that the underlying market remains attractive if the cost base is right.

To execute its strategy, Canal+, in a statement, said it has created a unified Africa management team under David Mignot, combining leadership from both legacy organisations to drive integration and capture synergies across the continent. 

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29